Brokerages Set Teleflex Incorporated (NYSE:TFX) Target Price at $140.83

Teleflex Incorporated (NYSE:TFX) has received an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $140.8333.

TFX has been the subject of a number of recent research reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Needham & Company LLC lifted their price target on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Royal Bank Of Canada boosted their price target on Teleflex from $115.00 to $125.00 and gave the stock a “sector perform” rating in a report on Friday, February 27th. Zacks Research downgraded Teleflex from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Finally, Truist Financial raised their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th.

Institutional Trading of Teleflex

Several institutional investors have recently modified their holdings of the business. Russell Investments Group Ltd. grew its position in shares of Teleflex by 23.6% in the 2nd quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock valued at $9,870,000 after buying an additional 15,935 shares during the last quarter. Capital International Investors bought a new position in shares of Teleflex during the third quarter worth about $44,851,000. Public Sector Pension Investment Board lifted its stake in shares of Teleflex by 24.9% in the third quarter. Public Sector Pension Investment Board now owns 188,208 shares of the medical technology company’s stock worth $23,029,000 after acquiring an additional 37,539 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Teleflex by 113.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock valued at $7,366,000 after acquiring an additional 30,912 shares during the last quarter. Finally, Invenomic Capital Management LP boosted its holdings in Teleflex by 35.6% in the third quarter. Invenomic Capital Management LP now owns 385,672 shares of the medical technology company’s stock valued at $47,191,000 after acquiring an additional 101,287 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of Teleflex stock opened at $105.29 on Friday. The company’s 50 day moving average price is $108.59 and its two-hundred day moving average price is $117.29. The firm has a market capitalization of $4.65 billion, a P/E ratio of -5.12, a P/E/G ratio of 0.66 and a beta of 0.87. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $143.32. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The company had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. During the same quarter last year, the company posted $3.89 earnings per share. The firm’s quarterly revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities analysts forecast that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 6th. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is presently -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.